EB-110（Eluminex Biosciences）

N/A

Report date: 2024/03/28 17:42:00

Base Information

Drug NameEB-110（Eluminex Biosciences）
Drug Alias NameEB-110
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsWet age-related macular degenerationRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEluminex Biosciences (Suzhou) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEluminex Biosciences (Suzhou) Ltd
Inactive CompaniesN/A
Active IndicationsWet age-related macular degenerationRetinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A